6OIM
Crystal Structure of human KRAS G12C covalently bound to AMG 510
Summary for 6OIM
Entry DOI | 10.2210/pdb6oim/pdb |
Descriptor | GTPase KRas, MAGNESIUM ION, GUANOSINE-5'-DIPHOSPHATE, ... (5 entities in total) |
Functional Keywords | inhibitor, gtpase, signaling protein |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 22068.73 |
Authors | Mohr, C. (deposition date: 2019-04-09, release date: 2019-11-06, Last modification date: 2019-12-18) |
Primary citation | Canon, J.,Rex, K.,Saiki, A.Y.,Mohr, C.,Cooke, K.,Bagal, D.,Gaida, K.,Holt, T.,Knutson, C.G.,Koppada, N.,Lanman, B.A.,Werner, J.,Rapaport, A.S.,San Miguel, T.,Ortiz, R.,Osgood, T.,Sun, J.R.,Zhu, X.,McCarter, J.D.,Volak, L.P.,Houk, B.E.,Fakih, M.G.,O'Neil, B.H.,Price, T.J.,Falchook, G.S.,Desai, J.,Kuo, J.,Govindan, R.,Hong, D.S.,Ouyang, W.,Henary, H.,Arvedson, T.,Cee, V.J.,Lipford, J.R. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 575:217-223, 2019 Cited by PubMed: 31666701DOI: 10.1038/s41586-019-1694-1 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.65 Å) |
Structure validation
Download full validation report